Borderline epithelial ovarian tumours.
Twenty-four patients with borderline epithelial ovarian tumours treated in the Department of Obstetrics and Gynaecology of Hacettepe University during the last 12 years were evaluated with regard to histopathology, therapeutic modalities employed and outcome. No mortality was encountered among the 23 patients with Stage 1 disease, regardless of the surgical mode of treatment or adjuvant therapy. The related literature was reviewed briefly to help enlighten the controversial issue of borderline ovarian tumours.
Ayhan
A
A
Department of Obstetrics and Gynaecology, Hacettepe University, School of Medicine, Ankara, Turkey.
Akarin
R
R
Develioglu
O
O
Yarali
H
H
Kücükali
T
T
Bilgin
F
F
D000328:Adult; D000368:Aged; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006785:Hospitals, University; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology*; D010052:Ovariectomy; D014421:Turkey / Q000453:epidemiology